Here's an update
from Supergate


post big3 featured
The BIG3 Innovation Field Startup Package Project

In recognition of Supergate's innovative system semiconductor design capabilities, it was selected for the BIG3 innovation start-up package business.

post investment series a featured
3.5 Billion Series A Investment Attractions

IBK Financial Group succeeded in attracting 3.5 billion won worth of Series A investment from the Investment Association and KB Securities.

post investment featured
13 billion won Series B Investment Attractions

Supergate has successfully attracted Series B investments from major domestic investors for its innovative technology and service performance.

post sedex 2023 featured
SEDEX 2023 Participation

On October 25, 2023, Supergate participated in the 'SEDEX 2023' held at COEX in Samseong-dong, Seoul.

post new stock issue 20230816 featured uai
New Share Issuance Announcement

Our company has resolved to issue new shares for third-party allocation on August 16, 2023, in accordance with the resolutions of the board of directors and Articles 9, 9-2, and 9-3 of our Articles of Incorporation and the relevant provisions of the Commercial Act.

post new stock issue 20220906 featured uai
New Share Issuance (Bonus Issue) Announcement

On September 6, 2022, our board of directors resolved to issue new shares (bonus issue) following the capitalization of reserves, and we hereby announce this decision.

post new stock issue 20220610 featured uai
New Share Issuance Announcement

Our company has resolved to issue new shares for third-party allocation on June 10, 2022, in accordance with the resolutions of the board of directors and Article 9, Clause 1, Item 2 of our Articles of Incorporation and the relevant provisions of the Commercial Act.

archive sample 4 featured
Wireless Charging Chips for Wearable Products

Supergate and Skychips have completed a deal to develop wearable wireless charging chips.

archive sample 3 featured uai
Joint Development with Asan Medical Center in Seoul, Smart CCTV

Supergate signed a joint research agreement with the research-oriented hospital R&D project group at Asan Medical Center in Seoul.